TCL Archive Cobimetinib-Zelboraf Therapy Increases OS In BRAF V600 Mutation-Positive Disease October 31, 2014
TCL Archive FDA Official Says Acceptance of PFS “Brings Us In Line With Our European Colleagues.” July 21, 2006
TCL Archive Dose Dense Chemo Study Published Early; Method Improves Breast Cancer Survival February 28, 2003
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
